Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.
- Revenue
- +3.95%
- EPS
- +34.8%
- Free cash flow
- −7.09%
- Total debt
- +15.6%
Quarter to September 2026, against a year earlier
Follow HSIC
Alert me
Henry Schein, Inc. (HSIC) EV/Sales
As of 5 November 2026, Henry Schein, Inc. (HSIC) trades at a EV/Sales of 0.9×. Over the past ten years it has ranged from 0.7× (April 2020) to 1.7× (December 2018); the current reading is higher than 19% of that period. That is in line with the Medical Distribution industry median of 0.9× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.9× | 3.25% |
| FY2024 | 0.8× | (12.94%) |
| FY2023 | 1.0× | 2.72% |
| FY2022 | 0.9× | (0.30%) |
| FY2021 | 0.9× | (3.04%) |
| FY2020 | 1.0× | (8.43%) |
| FY2019 | 1.1× | (3.30%) |
| FY2018 | 1.1× | 2.20% |
| FY2017 | 1.1× | 17.19% |
| FY2016 | 0.9× | (9.80%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 0.9× | (1.57%) |
| Jun 2026 | 0.9× | 8.16% |
| Mar 2026 | 0.8× | (6.92%) |
| Dec 2025 | 0.9× | 10.80% |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| YI 111, Inc. Sponsored ADR compare | 0.0× |
| COR Cencora, Inc. compare | 0.2× |
| CAH Cardinal Health, Inc. compare | 0.3× |
| MCK McKesson Corporation compare | 0.3× |
| COSM Cosmos Health Inc. compare | 0.4× |
| HSIC Henry Schein, Inc. | 0.9× |
| ACH Accendra Health, Inc. compare | 0.9× |
| AHG Akso Health Group Sponsored ADR compare | 1.7× |
| FOCL FocalTherics compare | 2.3× |
| Medical Distribution industry median | 0.9× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement